Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National …
Inaugural consensus statements were developed and endorsed by the American College of
Radiology (ACR) and the National Kidney Foundation to improve and standardize the care …
Radiology (ACR) and the National Kidney Foundation to improve and standardize the care …
Gadolinium‐based contrast agents: a comprehensive risk assessment
TJ Fraum, DR Ludwig, MR Bashir… - Journal of Magnetic …, 2017 - Wiley Online Library
Gadolinium‐based contrast agents (GBCAs) have been used in magnetic resonance
imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI …
imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI …
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
Medical imaging is routine in the diagnosis and staging of a wide range of medical
conditions. In particular, magnetic resonance imaging (MRI) is critical for visualizing soft …
conditions. In particular, magnetic resonance imaging (MRI) is critical for visualizing soft …
Metal and metal oxides nanoparticles and nanosystems in anticancer and antiviral theragnostic agents
TI Shabatina, OI Vernaya, NL Shimanovskiy… - Pharmaceutics, 2023 - mdpi.com
The development of antiviral treatment and anticancer theragnostic agents in recent
decades has been associated with nanotechnologies, and primarily with inorganic …
decades has been associated with nanotechnologies, and primarily with inorganic …
Gadolinium deposition and nephrogenic systemic fibrosis: a radiologist's primer
M Mathur, JR Jones, JC Weinreb - Radiographics, 2020 - pubs.rsna.org
Gadolinium-based contrast agents (GBCAs) have an excellent safety profile. However, over
the last 2 decades, two specific concerns have surfaced. GBCAs are associated with …
the last 2 decades, two specific concerns have surfaced. GBCAs are associated with …
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
HS Thomsen, SK Morcos, T Almén, MF Bellin… - European …, 2013 - Springer
Purpose To update the guidelines of the Contrast Media Safety Committee (CMSC) of the
European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and …
European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and …
Applications for transition-metal chemistry in contrast-enhanced magnetic resonance imaging
Contrast-enhanced magnetic resonance imaging (MRI) is an indispensable tool for
diagnostic medicine. However, safety concerns related to gadolinium in commercial MRI …
diagnostic medicine. However, safety concerns related to gadolinium in commercial MRI …
Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis
Purpose To perform a systematic review and meta-analysis to determine if there are
differences in rates of immediate allergic events between classes of gadolinium-based …
differences in rates of immediate allergic events between classes of gadolinium-based …
Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines
Gadolinium based contrast agents (GBCA) have been linked to the occurrence of
nephrogenic systemic fibrosis (NSF) in renal impaired patients. The exact interaction …
nephrogenic systemic fibrosis (NSF) in renal impaired patients. The exact interaction …
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic …
R Knobler, P Moinzadeh, N Hunzelmann… - Journal of the …, 2017 - Wiley Online Library
The term 'sclerosing diseases of the skin'comprises specific dermatological entities which
have fibrotic changes of the skin in common. These diseases mostly manifest in different …
have fibrotic changes of the skin in common. These diseases mostly manifest in different …